Herantis Pharma Oyj: Manager’s Transactions – Pekka Simula

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}

Herantis Pharma Oyj: Manager's Transactions - Pekka Simula

Herantis Pharma Plc
Company release 22 October 2018 at 9:00 am

Herantis Pharma Oyj - Managers' Transactions

____________________________________________

Person subject to the notification requirement

Name: Pekka Simula

Position: Chief Executive Officer

Issuer: Herantis Pharma Oyj

LEI: 743700W4CQVYAT3WKK38

Notification type: INITIAL NOTIFICATION

Reference number: 743700W4CQVYAT3WKK38_20181020161010_2

____________________________________________

Transaction date: 2018-10-18

Venue: FIRST NORTH FINLAND (FNFI)

Instrument type: SHARE

ISIN: FI4000087861

Nature of the transaction: ACQUISITION

Transaction details

(1): Volume: 200 Unit price: 5.55 EUR

(2): Volume: 200 Unit price: 5.3 EUR

Aggregated transactions

(2): Volume: 400 Volume weighted average price: 5.425 EUR

____________________________________________

Transaction date: 2018-10-19

Venue: FIRST NORTH FINLAND (FNFI)

Instrument type: SHARE

ISIN: FI4000087861

Nature of the transaction: ACQUISITION

Transaction details

(1): Volume: 200 Unit price: 5.95 EUR

Aggregated transactions

(1): Volume: 200 Volume weighted average price: 5.95 EUR

____________________________________________

Further information:

Herantis Pharma Plc, Pekka Simula, CEO, telephone: +358 40 7300 445
Company web site: www.herantis.com
Certified Advisor: UB Securities Ltd, telephone: +358 9 25 380 225

Distribution:

Nasdaq Helsinki
Main media
www.herantis.com